Results for tag: Non-Hodgkin lymphoma Total Items Found: 12

Michael LaRiviere on Non-Hodgkin Lymphoma Induction Radiation Before CAR T-Cell Therapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
astro annual meeting
car t-cell
chimeric antigen receptor
induction radiotherapy
lymphoma
Non-Hodgkin lymphoma

Created: 9/20/2019 8:42:24 PM

Julie Vose and Merav Bar on Late Effects of CD19-Targeted Treatment

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2018
CAR T cell therapy
CD-19
non-Hodgkin lymphoma
leukemia
chronic lymphocytic leukemia
CLL

Created: 12/3/2018 9:24:24 PM

John Leonard on NHL: Results From the AUGMENT Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2018
AUGMENT trial
lenalidomide
rituximab
non-Hodgkin lymphoma
lymphoma
indolent lymphoma
relapsed
refractory

Created: 12/3/2018 5:40:25 PM

Julie Vose and David Maloney on Update on NHL CAR T Cell Therapies

Type of Page:TapVideo
Edit This Item
Tags for this item:
Pan Pacific Lymphoma
Non-Hodgkin lymphoma
lymphoma
CAR T-cell therapy
efficacy
toxicity
ease of use
clinical resources

Created: 7/25/2018 3:23:53 PM

Andrew Zelenetz on Clinical Applications of Genomic Studies

Type of Page:TapVideo
Edit This Item
Tags for this item:
Pan Pacific Lymphoma
non-Hodgkin lymphoma
genomic studies
genomics

Created: 7/24/2018 6:21:10 PM

Jeremy Abramson on Results From the TRANSCEND NHL 001 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
non-Hodgkin lymphoma
NHL
TRANSCEND NHL 001
lisocabtagene maraleucel

Created: 6/3/2018 8:16:38 PM

Andrew D. Zelenetz, MD, PhD, and Sattva S. Neelapu, MD, on NHL: Results From the ZUMA-1 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
NHL
non-Hodgkin lymphoma
ZUMA-1 trial
axicabtagene ciloleucel
refractory disease
long-term results

Created: 12/11/2017 12:48:26 PM

Sharyn L. Kurtz, PA-C, MPAS, MA, on Managing Lymphoma Survivors

Type of Page:TapVideo
Edit This Item
Tags for this item:
NCCN Hematologic Malignancies
Sharyn Kurtz
Dana-Farber Cancer Institute
cancer survivor
lymphoma
survivorship
Hodgkin lymphoma
non-Hodgkin lymphoma
long-term side effects

Created: 10/11/2017 4:13:40 PM

Laurie H. Sehn, MD, MPH, and James O. Armitage, MD, on Results of the GADOLIN Trial on Indolent Non-Hodgkin Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Laurie Helen Sehn
British Columbia Cancer Agency
James Armitage
GADOLIN
obinutuzumab
bendamustine
rituximab-refractory
indolent non-Hodgkin lymphoma
non-Hodgkin lymphoma
University of Nebraska Medical
ASCO 2015

Created: 1/31/2016 9:04:47 AM

Julie Vose, MD, MBA, and John F. Gerecitano, MD, PhD, on Venetoclax for NHL

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Julie Vose
University of Nebraska Medical C
John Gerecitano
Memorial Sloan Kettering
NHL
non-Hodgkin lymphoma
venetoclax
monotherapy
relapsed/refractory

Created: 12/24/2015 12:25:03 PM

Craig H. Moskowitz, MD, on NHL: Early Study Results on Denintuzumab Mafodotin

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Craig Moskowitz
Memorial Sloan Kettering
NHL
non-Hodgkin lymphoma
anti-CD19 monoclonal antibody
denintuzumab mafodotin
relapsed/refractory disease

Created: 12/24/2015 12:13:37 PM

Ronald Go, MD, on Survival in NHL and Treatment Facility Volume

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2015
Ronald Go
Mayo Clinic
National Cancer Database
NHL
Non-Hodgkin lymphoma
facility volume
overall survival

Created: 12/3/2015 4:13:57 PM
Order By Item Count
Order Alphabetically